You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Table TDI-10 part (i). New clients entering outpatient treatment: age and primary drug at treatment in 2003 for those countries supplying data. Age distribution (row percentage) for each primary drug type: summary

Substance

<15

15-19

20-24

25-29

30-34

35-39

40-44

45+

Age known (base)

Age not known

Opiates

1.1

9.2

27.1

23.3

17.7

11.4

5.7

4.5

22176

203

Cocaine

0.5

9.7

23.3

22.2

19.3

13.4

7.0

4.7

6129

72

Stimulants

1.3

26.4

32.4

17.6

10.6

6.8

3.0

2.0

4459

13

Hypnotics/sedatives

0.6

8.3

13.2

12.2

13.2

11.3

10.9

30.3

1563

48

Hallucinogens

0.0

28.8

25.0

11.3

7.5

4.4

3.8

19.4

160

0

Volatiles

31.4

44.8

9.0

5.9

4.8

1.7

2.0

0.6

357

0

Cannabis

5.5

39.0

29.2

12.6

6.5

3.6

2.0

1.7

15681

54

Other substances

1.3

12.7

24.0

18.4

12.4

13.3

7.9

10.0

1255

19

Total

2.6

20.1

27.1

18.8

13.5

8.8

4.7

4.4

51780

409

Notes 

The countries supplying data are: 

CZ, DK, DE, EL, CY, LV, HU, MT, NL, SK, SI, FI, SE, UK, BG, RO.

The number of treatment clients in each country is listed in [Table TDI-7]. 

Source:

2004 Reitox national reports - TDI outpatient treatment centres – see [Table TDI-14]

Data filter | tditab10a-en.xml